IMPORTANT AT$T RETIREE BENEFITS INFORMATION AT$T Eligible Former Employee CarePlus – A Supplemental Benefit Program Changes Effective August 1, 2019
IMPORTANT AT$T RETIREE BENEFITS INFORMATION
AT$T Eligible Former Employee CarePlus – A Supplemental Benefit Program
Effective August 1, 2019
HIGHLIGHTS
The highlights below are provided to help you understand the changes described in this SMM effective August 1, 2019. Please use this SMM along with the SPD for the Program for complete information. For full information, you must consider all of the information in the SPD, as amended by any applicable SMMs.
The changes include:
- Five new “Experimental Services” are added:
− RESPeRATE for treatment of Hypertension
− Cardiac Contractility Modulation for treatment of moderate-to-severe heart failure
− Extracorporeal Shock Wave Treatment (ESWT) for the treatment of diabetic foot ulcers
− Transcranial Magnetic Stimulation (TMS) for treatment of migraines for adolescent patients
− Zulresso (Brexanolone) Intravenous IV Drug for treatment of postpartum depression – (Under consideration for coverage under Base Medical Programs, if covered under your Base Medical Program, coverage is not available under this Program)One service is moved from “Experimental Services” to the “Expanded Services” section:
- One service is moved from “Experimental Services” to the “Expanded Services” section:
- − Freestyle Libre Pro Flash Glucose Monitoring System
- One new service is added to the “Expanded Services” section:
- − Durable Medical Equipment reimbursement for certain diabetic supplies and lightweight wheelchairs
Download Copy of SMM in PDF Format Under Article Files Below
